1 results match your criteria: "Hadassah University Hospital and The Hebrew University-Hadassah School Of Dental Medicine[Affiliation]"
Budesonide: a novel treatment for oral chronic graft versus host disease.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
March 2003
Hospital Oral Medicine Department, Hadassah University Hospital and The Hebrew University-Hadassah School Of Dental Medicine, Jerusalem, Israel.
Objective: This clinical trial aims to evaluate the efficacy of budesonide, a newly registered steroid with high potency and low bioavailability, for the treatment of chronic oral graft versus host disease (GVHD).
Study Design: Twelve patients with chronic resistant oral GVHD were treated with 3 mg budesonide/5 ml saline 2 to 3 times a day for up to 3 months. Oral manifestations were monitored, and mucosal response scored.